Chong Kun Dang Pharmaceutical Working Capital to Net Assets Ratio
Chong Kun Dang Pharmaceutical working capital to net assets ratio. Chong Kun Dang Pharmaceutical (185750) has a Working Capital to Net Assets ratio of 50.8% as of March 2026. Working capital of ₩522.64 Billion (current assets of ₩1.05 Trillion minus current liabilities of ₩522.52 Billion) is measured against net assets of ₩1.03 Trillion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Chong Kun Dang Pharmaceutical to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Chong Kun Dang Pharmaceutical (2016–2025)
Working capital to net assets ratio of Chong Kun Dang Pharmaceutical from 2016 to 2025. This chart shows how Chong Kun Dang Pharmaceutical's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 50.8%, reflecting working capital of ₩522.64 Billion against net assets of ₩1.03 Trillion KRW. See 185750 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Chong Kun Dang Pharmaceutical Working Capital to Net Assets Ratio by Year (2016–2025)
Chong Kun Dang Pharmaceutical working capital to net assets ratio by year from 2016 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Chong Kun Dang Pharmaceutical from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Chong Kun Dang Pharmaceutical total assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 57.2% | ₩575.69 Billion | ₩1.01 Trillion | ₩1.09 Trillion | ₩516.12 Billion | ▼ -9.0 pp |
| 2024 | 66.2% | ₩593.59 Billion | ₩896.38 Billion | ₩962.15 Billion | ₩368.56 Billion | ▲ +12.9 pp |
| 2023 | 53.3% | ₩435.11 Billion | ₩815.64 Billion | ₩946.57 Billion | ₩511.47 Billion | ▼ -1.3 pp |
| 2022 | 54.6% | ₩339.40 Billion | ₩621.29 Billion | ₩713.61 Billion | ₩374.21 Billion | ▼ -6.7 pp |
| 2021 | 61.3% | ₩346.92 Billion | ₩565.81 Billion | ₩667.15 Billion | ₩320.23 Billion | ▲ +10.6 pp |
| 2020 | 50.7% | ₩279.49 Billion | ₩551.59 Billion | ₩600.11 Billion | ₩320.62 Billion | ▲ +9.8 pp |
| 2019 | 40.9% | ₩194.07 Billion | ₩474.95 Billion | ₩471.14 Billion | ₩277.07 Billion | ▼ -2.3 pp |
| 2018 | 43.1% | ₩185.82 Billion | ₩430.90 Billion | ₩390.33 Billion | ₩204.51 Billion | ▲ +7.7 pp |
| 2017 | 35.4% | ₩142.86 Billion | ₩403.29 Billion | ₩366.90 Billion | ₩224.05 Billion | ▼ -0.5 pp |
| 2016 | 35.9% | ₩127.32 Billion | ₩354.25 Billion | ₩338.76 Billion | ₩211.44 Billion | — |